Sarcoma Service at Memorial Sloan Kettering

For more than 135 years, we have been united by a singular purpose: to find cures for sarcomas.

1-844-923-0361 (new pts) | [email protected] (doctors)

[SARC @SARCtrials]

The July episode of #SARCTalk features Dr. Mark Dickson, MD from @MSKCancerCenter sharing valuable insight on #liposarcoma.

Listen now on Spotify! Also available on Apple Podcast and YouTube. https://t.co/CdwtcDltOK

#sarcoma #SARCtrials @MSKSarcoma

[Sarcoma Service at Memorial Sloan Kettering @MSKSarcoma]

Featured today by @MSKLibrary: A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma https://t.co/gNRmawooF8

[Cancer Research Institute @CancerResearch]

"This grant is meaningful to me because it allows me to continue my research which is focused on novel immunotherapies for rare pediatric cancers," shares CRI-Bristol Myers Squibb Fellow Dr. Lauren Banks of @MSKCancerCenter. Learn more: https://t.co/FLZwlU1Gat #CancerResearch

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

On 4/26, we're launching a global educational series on molecular oncology, co-directed by MSK's Dr. Mrinal Gounder and @SewantiLimaye of @RFhospital Mumbai, to examine cancer signaling pathways and discuss nuances of precision therapies. Register today! https://t.co/AhceNM1nuN

[Sandra P D'Angelo, MD @sandrapdangelo]

Dr. Kelly shows that pembrolizumab + epacadostat is ineffective in #sarcoma but correlative studies noted lack of IDO inhibition. Provides some important insight into potential mechanism of drug failure, leaving many unanswered questions. @MSKSarcoma @MSK_DeptOfMed

[Sarcoma Service at Memorial Sloan Kettering @MSKSarcoma]

We are thrilled to welcome Dr. Bob Maki back to the MSK family. Dr. Maki brings long-standing expertise in #sarcoma through innovative research and trials. A dedicated colleague, mentor, friend and a compassionate clinician. Clinics in Manhattan and Nassau campus. Welcome Bob!

[Sandra P D'Angelo, MD @sandrapdangelo]

As a recipient of numerous ASCO Conquer Cancer grants, I can attest to the power and value of these opportunities. https://t.co/HjA8Lk3ZIR. @MSKSarcoma @MSK_DeptOfMed @ASCO @ConquerCancerFd

[Sarcoma Service at Memorial Sloan Kettering @MSKSarcoma]

Nirogacestat, a New Desmoid Tumor Treatment, Improves Outcomes for People With Sarcoma https://t.co/1nQOgFn8Lw @AimeeCragoMD Dr. Sam Singer, MSK, Dr. Joe Erinjeri, Dr. Robert Lefkowitz @DTRFoundation @AmericanCancer @SpringWorksTx @RareDiseases @debschrag

[Sarcoma Service at Memorial Sloan Kettering @MSKSarcoma]

Congratulations to all desmoid pts/families, pt advocacy @DTRFoundation, Mrinal Gounder @MSKCancerCenter desmoid team, co-investigators globally, @SpringWorksTx. A great model for drug development in @RareDiseases - pt advocacy working together w academia, industry & regulators.

[TODAY with Jenna & Sheinelle @JennaSheinelle]

Mrs. @MichelleObama has received nearly 2,000 letters every month — which are part of the inspiration behind her new book “The Light We Carry.”

Take a look at the story of one woman who wrote a letter in 2020 and found comfort in Mrs. Obama’s words during a difficult time.

[Sandra P D'Angelo, MD @sandrapdangelo]

MSK fellow extraordinaire, Dr. Lauren Banks provides insightful perspective into the status of immunotherapy for sarcoma. Privileged to co-mentor with Dr. Klebanoff with whom she's conducting ground breaking research @KlebanoffLab @WTapMD @MSK_DeptOfMed

[The Life Raft Group @Liferaftgroup]

Share your story.
https://t.co/qazVUT5Wr2

[Sarcoma Foundation of America @CureSarcoma]

Rare, often misdiagnosed, accounts for 1% of all adult cancers and 15 to 20% of childhood cancers. In 2022, an estimated 17,000 people will be diagnosed, and over 7,200 people will die, 42% of diagnosed cases.

Read more here: https://t.co/J0CNeiLgTo

#sarcomaawarenessmonth

[Sarcoma Alliance @SarcomaAlliance]

It's officially #SarcomaAwarenessMonth. Will you retweet to raise sarcoma awareness?

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

Excited to announce @DrVickersUAB of @uabnews has been selected to serve as MSK President and CEO beginning this September. He is an internationally recognized pancreatic cancer surgeon and researcher and an academic medical leader. https://t.co/oW0p91ymQG

[Sandra P D'Angelo, MD @sandrapdangelo]

Nivolumab with bempegaldesleukin in sarcoma now published in @NatureComms. A collaborative effort with my colleagues @MSKSarcoma, @WTapMD, MSK computational biologists (Allison Richards, Mark Donoghue) and MDA colleagues @APConley77) https://t.co/YmdAxhQVdD @MSKCancerCenter 1/8

[Ben Nacev, MD PhD @BenNacev]

Our latest work is out in @NatureComms. With @fsanchezvega, @WTapMD, Samuel Singer, and colleagues at @MSKSarcoma
@MSKCancerCenter, we present a genomic analysis of 2,138 tumors representing 45 subtypes of soft tissue and bone #sarcoma (1/x). 🧵

https://t.co/t5dwktvDuy

[Aimee Crago, M.D. @AimeeCragoMD]

We're looking for a new postdoc to help with our NIH project on #desmoid tumors. Email or DM if you know someone who might be interested! https://t.co/rCUqHbBdO2